A recent report showed that treatment with HDAC and DNA methylation inhibitors triggered an IFN response in a lung cancer model,41 supporting the hypothesis that regulation of this pathway is highly dependent on histone deacetylation. Here, HDAC9 is linked to lung carcinoma.